Allergy and Immunology · Honolulu, HI
NPI
1306041967
Since 2007
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1380 Lusitana St Ste 604
Honolulu, HI, 96813
Phone (808) 523-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
4,323 services
Medicare patients, 2024
424
Average age 74
Drug cost, 2024
$1.4M
3,145 prescriptions
Company payments, 2025
$4,530
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abigail S Harada was code 95004 (test - miscellaneous), 3,288 times for 75 patients. In total Abigail S Harada billed 4,323 services in 12 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 3,288 | 75 | $2.81 | $9,231 |
| 99213 Office E&M - Established | Office | 340 | 298 | $66.24 | $23K |
| 94375 Pulmonary Function Testing | Office | 249 | 218 | $31.29 | $7,791 |
| 99204 Office E&M - New | Office | 89 | 89 | $125.94 | $11K |
| 99214 Office E&M - Established | Office | 66 | 63 | $101.49 | $6,698 |
| 99212 Office E&M - Established | Office | 47 | 26 | $34.07 | $1,601 |
By year: 2022 $68K for 4,153 services; 2023 $63K for 3,891 services; 2024 $63K for 4,323 services.
Medicare prescription drug claims, 2024
In 2024, the drug Abigail S Harada prescribed most often to Medicare patients was Montelukast Sodium, with 710 prescriptions and refills. In total Abigail S Harada wrote 3,145 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 710 | 2,102 | 226 | $26K |
| Ipratropium Bromide Generic | 359 | 650 | 181 | $23K |
| Fluticasone Propionate Generic | 269 | 780 | 147 | $5,362 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 202 | 215 | 125 | $5,703 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 133 | 380 | 66 | $32K |
| Dupixent Pen Dupilumab | 126 | 126 | 12 | $530K |
| Azelastine Hcl Generic | 119 | 284 | 62 | $7,801 |
| Mometasone Furoate Generic | 112 | 299 | 39 | $24K |
| Levocetirizine Dihydrochloride Generic | 100 | 295 | 38 | $3,824 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 70 | 148 | 20 | $92K |
| Nucala Mepolizumab | 56 | 56 | Under 11 | $326K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 50 | 116 | 24 | $10K |
| Famotidine Generic | 46 | 118 | 21 | $1,349 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 46 | 76 | 17 | $47K |
| Olopatadine Hcl Generic | 45 | 114 | 32 | $5,513 |
Brand drugs: 741 claims; generic drugs: 2,404 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abigail S Harada $4,530 ($4,530 in general payments such as food, travel and fees) from 27 companies. The largest payer was Genzyme Corporation with $596.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 13 | $596 |
| AstraZeneca Pharmaceuticals LP AZN | 21 | $510 |
| LEO Pharma Inc. | 17 | $449 |
| GlaxoSmithKline, LLC. GSK | 45 | $442 |
| Galderma Laboratories, L.P. GALD.SW | 8 | $325 |
| Lilly USA, LLC LLY | 8 | $259 |
| CSL Behring CSL.AX | 9 | $249 |
| Genentech USA, Inc. ROG.SW | 15 | $249 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 22 | $232 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $230 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.